These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27281309)

  • 1. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
    Meckel K; Li YC; Lim J; Kocherginsky M; Weber C; Almoghrabi A; Chen X; Kaboff A; Sadiq F; Hanauer SB; Cohen RD; Kwon J; Rubin DT; Hanan I; Sakuraba A; Yen E; Bissonnette M; Pekow J
    Am J Clin Nutr; 2016 Jul; 104(1):113-20. PubMed ID: 27281309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis Patients.
    Tan Y; Guan Y; Sun Y; Zheng C
    Am J Med Sci; 2019 Mar; 357(3):195-204. PubMed ID: 30638599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxibustion regulates inflammatory mediators and colonic mucosal barrier in ulcerative colitis rats.
    Ma TM; Xu N; Ma XD; Bai ZH; Tao X; Yan HC
    World J Gastroenterol; 2016 Feb; 22(8):2566-75. PubMed ID: 26937144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative Colitis.
    Sauer CG; Loop MS; Venkateswaran S; Tangpricha V; Ziegler TR; Dhawan A; McCall C; Bonkowski E; Mack DR; Boyle B; Griffiths AM; Leleiko NS; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Davis S; Patel S; Wang J; Marquis A; Spada KL; Kugathasan S; Walters T; Hyams JS; Denson LA
    Inflamm Bowel Dis; 2018 Feb; 24(3):641-650. PubMed ID: 29462384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How would serum 25(OH)D level change in patients with inflammatory bowel disease depending on intestinal mucosa vitamin D receptor (VDR) and vitamin D1-α hydroxylase (CYP27B1)?
    Huang J; Chen T; Liu Y; Lyu L; Li X; Yue W
    Turk J Gastroenterol; 2019 Feb; 30(2):132-138. PubMed ID: 30429108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Vitamin D Receptor on Mucosal Barrier Proteins in Colon Cells under Hypoxic Environment].
    Wang Z; Yang H; Jin M; Zhang HM; Chen XF; Wu MX; Guo MY; Huang CZ; Qian JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):506-511. PubMed ID: 31484613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Mucosa-associated Butyricicoccus Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression.
    Devriese S; Eeckhaut V; Geirnaert A; Van den Bossche L; Hindryckx P; Van de Wiele T; Van Immerseel F; Ducatelle R; De Vos M; Laukens D
    J Crohns Colitis; 2017 Feb; 11(2):229-236. PubMed ID: 27484096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
    Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
    Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Vitamin D Receptor Signalling and Vitamin D on Colonic Epithelial Cell Fate Decisions in Ulcerative Colitis.
    Kellermann L; Hansen SL; Maciag G; Granau AM; Johansen JV; Teves JM; Bressan RB; Pedersen MT; Soendergaard C; Baattrup AM; Hammerhøj A; Riis LB; Gubatan J; Jensen KB; Nielsen OH
    J Crohns Colitis; 2024 Oct; 18(10):1672-1689. PubMed ID: 38747639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease.
    Abreu-Delgado Y; Isidro RA; Torres EA; González A; Cruz ML; Isidro AA; González-Keelan CI; Medero P; Appleyard CB
    World J Gastroenterol; 2016 Apr; 22(13):3581-91. PubMed ID: 27053850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
    Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
    Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial Cells.
    Gubatan J; Mehigan GA; Villegas F; Mitsuhashi S; Longhi MS; Malvar G; Csizmadia E; Robson S; Moss AC
    Inflamm Bowel Dis; 2020 May; 26(6):885-897. PubMed ID: 31955203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D regulates the tight-junction protein expression in active ulcerative colitis.
    Stio M; Retico L; Annese V; Bonanomi AG
    Scand J Gastroenterol; 2016 Oct; 51(10):1193-9. PubMed ID: 27207502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity.
    Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL
    J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-Dependent Induction of Colonic Cyp27b1 Is Associated With Colonic Inflammation: Implications of Locally Produced 1,25-Dihydroxyvitamin D3 in Inflammatory Regulation in the Colon.
    Du J; Wei X; Ge X; Chen Y; Li YC
    Endocrinology; 2017 Nov; 158(11):4064-4075. PubMed ID: 28938443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis.
    Wang HQ; Zhang WH; Wang YQ; Geng XP; Wang MW; Fan YY; Guan J; Shen JL; Chen X
    World J Gastroenterol; 2020 Dec; 26(46):7352-7366. PubMed ID: 33362389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
    Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
    Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis.
    Ariturk LA; Cilingir S; Kolgazi M; Elmas M; Arbak S; Yapislar H
    Eur J Nutr; 2024 Oct; 63(7):2801-2813. PubMed ID: 39105785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.